These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 34717608)
1. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study. Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608 [TBL] [Abstract][Full Text] [Related]
2. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Vicariotto F; Raichi M Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062 [TBL] [Abstract][Full Text] [Related]
3. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Vicariotto F; DE Seta F; Faoro V; Raichi M Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667 [TBL] [Abstract][Full Text] [Related]
4. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM). Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731 [TBL] [Abstract][Full Text] [Related]
5. Microablative fractional radiofrequency for the genitourinary syndrome of menopause: protocol of randomised controlled trial. Sarmento ACA; Fernandes FS; Costa APF; Medeiros KS; Crispim JC; Gonçalves AK BMJ Open; 2021 Jul; 11(7):e046372. PubMed ID: 34226218 [TBL] [Abstract][Full Text] [Related]
6. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Gambacciani M; Levancini M; Cervigni M Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of non-ablative CO Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692 [TBL] [Abstract][Full Text] [Related]
8. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis. Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378 [TBL] [Abstract][Full Text] [Related]
9. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study. Mercier J; Morin M; Zaki D; Reichetzer B; Lemieux MC; Khalifé S; Dumoulin C Maturitas; 2019 Jul; 125():57-62. PubMed ID: 31133219 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial. Gueldini de Moraes AV; Costa-Paiva L; da Costa Machado H; Maciel TF; Mariano FV; Pedro AO Menopause; 2024 Apr; 31(4):288-302. PubMed ID: 38412393 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a device that combines multipolar radiofrequency with pulsed electromagnetic field for the treatment of vulvovaginal atrophy: a randomized, sham-controlled trial. Nappi RE; Martella S; Tiranini L; Cucinella L; Palacios S J Sex Med; 2024 Feb; 21(3):203-210. PubMed ID: 38286753 [TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047 [TBL] [Abstract][Full Text] [Related]
13. Relationship Between Genitourinary Syndrome of Menopause and 3D High-Frequency Endovaginal Ultrasound Measurement of Vaginal Wall Thickness. Peker H; Gursoy A J Sex Med; 2021 Jul; 18(7):1230-1235. PubMed ID: 34193368 [TBL] [Abstract][Full Text] [Related]
14. Rationale and design for fractional microablative CO Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818 [TBL] [Abstract][Full Text] [Related]
15. A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause. Agrawal S; LaPier Z; Nagpal S; Oot A; Friedman S; Hade EM; Nachtigall L; Brucker BM; Escobar C Menopause; 2024 Sep; 31(9):750-755. PubMed ID: 39042017 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause. Barba M; Cola A; De Vicari D; Costa C; Castelli AP; Volontè S; Fruscio R; Frigerio M Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892888 [TBL] [Abstract][Full Text] [Related]
17. Randomized trial: treatment of genitourinary syndrome of menopause using radiofrequency. Joris A; Di Pietrantonio V; Praet J; Renard K; Verduyn AC; Buxant F; Rozenberg S Climacteric; 2024 Apr; 27(2):210-214. PubMed ID: 38251861 [TBL] [Abstract][Full Text] [Related]
18. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency. Kamilos MF; Borrelli CL Einstein (Sao Paulo); 2017; 15(4):445-451. PubMed ID: 29364367 [TBL] [Abstract][Full Text] [Related]